Verification evidence is still being completed.
PDF / print export
SUN bioscience SA
Lausanne, Switzerland
- Verified lead
- Sylke Hoehnel
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Gri3D Microwell Organoid Array, Organoid Technology, and Cystic Fibrosis Diagnostic Development
- Review cycle
- 24 April 2026
- Full address
- EPFL Innovation Park, Building D, 1015 Lausanne, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Biopole announcement naming Sylke Hoehnel as Co-Founder and CEO of SUN Bioscience.
- Editorial note
- EPFL Innovation Park spin-off with named co-founder CEO, Gri3D organoid microwell platform, and public cystic fibrosis diagnostic development.
Gri3D Microwell Organoid Array, Organoid Technology, and Cystic Fibrosis Diagnostic Development
EPFL spin-off, Biopole StartLab membership, Public co-founder CEO disclosure
EPFL Innovation Park spin-off with named co-founder CEO, Gri3D organoid microwell platform, and public cystic fibrosis diagnostic development.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Lausanne, Switzerland
SUN bioscience SA
Gri3D Microwell Organoid Array, Organoid Technology, and Cystic Fibrosis Diagnostic Development · Research-tools and diagnostic service delivery
EPFL Innovation Park spin-off with named co-founder CEO, Gri3D organoid microwell platform, and public cystic fibrosis diagnostic development.
- Lead
- Sylke Hoehnel (verified ↗)
- Address
- EPFL Innovation Park, Building D, 1015 Lausanne, Switzerland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Research-tools and diagnostic service delivery
- Capabilities
- Gri3D Microwell Array Platform · Organoid Generation Services · Cystic Fibrosis Diagnostic Development
- Founded
- 2015
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Sylke Hoehnel
Chief Executive Officer and Co-Founder
Full addressEPFL Innovation Park, Building D, 1015 Lausanne, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
Switzerland Innovation report placing SUN Bioscience in the EPFL Innovation Park Building D, Lausanne.
Open sourceResearch-tools and diagnostic service delivery
Lausanne, Switzerland. Gri3D Microwell Organoid Array, Organoid Technology, and Cystic Fibrosis Diagnostic Development. Review completed on 24 Apr 2026.
Swiss quality standards for research tools
EPFL spin-off, Biopole StartLab membership, Public co-founder CEO disclosure
Gri3D Microwell Organoid Array, Organoid Technology, and Cystic Fibrosis Diagnostic Development
EPFL Innovation Park spin-off with named co-founder CEO, Gri3D organoid microwell platform, and public cystic fibrosis diagnostic development.
Editorial note
SUN bioscience is an EPFL spin-off with a named co-founder CEO, a Gri3D microwell organoid array product line, StartLab incubator membership, and ongoing cystic fibrosis diagnostic development.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Gri3D Microwell Array Platform
Organoid Generation Services
Cystic Fibrosis Diagnostic Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Gri3D microwell array production
Organoid culture workflow
Diagnostic development infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is SUN bioscience SA located?
- SUN bioscience SA operates from EPFL Innovation Park, Building D, 1015 Lausanne, Switzerland, Lausanne, Switzerland.
- Who runs SUN bioscience SA?
- SUN bioscience SA is led by Sylke Hoehnel, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What does SUN bioscience SA do?
- EPFL Innovation Park spin-off with named co-founder CEO, Gri3D organoid microwell platform, and public cystic fibrosis diagnostic development. Core capabilities: Gri3D Microwell Array Platform, Organoid Generation Services, Cystic Fibrosis Diagnostic Development.
Editorial context
Related technical briefs
Briefs that name Lausanne as a covered market or city.